WebHeart Failure (HF) is a major public health issue with an estimated prevalence of over 37.7 million individuals worldwide [1], and remains the leading cause of morbidity, mortality, … WebApr 8, 2024 · Alternative splicing is a regulatory mechanism essential for cell differentiation and tissue organization. More than 90% of human genes are regulated by alternative …
Is RBM20 a Promising Target for HFpEF Therapy?
WebApr 12, 2024 · RBM20 is a heart- and skeletal muscle–enriched splicing factor that controls tissue-specific isoform expression of many other genes besides TTN, including … WebHuman genetic variation in the NPR1 ... Therefore, we compared biomarker profiles to characterize pathophysiological differences between patients with HFrEF and HFpEF. In HFpEF, inflammation and angiogenesis‐mediated interactions are predominantly observed, while stretch‐mediated ... Mutations in RBM20 (RNA-binding motif protein 20) ... theorg vertrieb
RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin
WebDec 1, 2024 · The latest study revealed that inhibition of RBM20 with antisense oligonucleotides (ASOs) in HFpEF mouse and engineered human heart tissue improved … WebIn a study published by van Veldhuisen et al the HFpEF patients in the middle BNP value group (251–750 pg/mL; median: 450 pg/mL) had a hazard ratio of 1.50 for death and HF hospitalization. 36 The findings that BNP is the primary driver of outcomes, and that adding LVEF has limited value in prognostication, have been reported previously in patients with … WebFeb 18, 2024 · RBM20 is a disease-causing gene associated with dilated cardiomyopathy (DCM). The proband presented with the dilated phase of hypertrophic cardiomyopathy … theorg treiber